PMID: 16634365Apr 26, 2006Paper

Mixed connective tissue disease

Lupus
P J W Venables

Abstract

Mixed connective tissue disease (MCTD) was first described in 1972 as a disease syndrome with overlapping features of systemic sclerosis, systemic lupus erythematosus (SLE) and polymyositis associated with antibodies to RNAse sensitive extractable nuclear antigen. When the antigen was subsequently characterized as polypeptides on the U1 ribonuclear protein component of the splicesosome (U1RNP), MCTD became the first rheumatic disease syndrome to be defined by a serologic test. Clinical features include a high frequency of Raynaud's syndrome, swollen hands, sclerodactyly, arthritis, polymyositis and interstitial lung disease. Over the last 30 years there has been a continuing debate as to whether MCTD constitutes a 'distinct clinical entity'. Here, I will review the pathological, immunogenetic and clinical features of MCTD and conclude that the debate remains unresolved. The early misconception that it has a relatively good prognosis has not stood the test of time with long-term follow-up studies. These have identified a tendency for MCTD to evolve into SLE or systemic sclerosis and highlighted pulmonary hypertension and scleroderma renal crisis as important causes of death. Providing it is realized that our appreciation of the ...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M R Lerner, J A Steitz
Oct 1, 1978·Annals of the Rheumatic Diseases·R M Bennett, D J O'Connell
Oct 1, 1990·The Quarterly Journal of Medicine·C MarguerieM J Walport
May 1, 1990·Gastroenterology·J B MarshallG C Sharp
Jan 1, 1988·Arthritis and Rheumatism·C M BlackR S Pereira
Apr 1, 1995·Seminars in Arthritis and Rheumatism·C A von Mühlen, E M Tan
Feb 1, 1993·The American Journal of the Medical Sciences·B Mukerji, J G Hardin
Sep 16, 2000·Current Opinion in Rheumatology·R W Hoffman, E L Greidinger
Aug 9, 2005·Rheumatic Diseases Clinics of North America·Josephine Swanton, David Isenberg

❮ Previous
Next ❯

Citations

May 22, 2008·Rheumatology International·Hideki NakamuraKatsumi Eguchi
Nov 23, 2006·Clinical Rheumatology·Mehmet CelikbilekNurhan F Ozdemir
Oct 5, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giorgio TascaEnzo Ricci
Dec 30, 2011·Journal of Assisted Reproduction and Genetics·Vasileios D Sioulas, Clarisa R Gracia
Jun 1, 2012·Clinical Reviews in Allergy & Immunology·Juan-Manuel AnayaMauricio Arcos-Burgos
Oct 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ayumi OmokawaHideki Wakui
Aug 11, 2011·Pediatric Rheumatology Online Journal·Jessica L RecordRandy Q Cron
Feb 16, 2008·Journal of Autoimmune Diseases·Masha Fridkis-Hareli
Jun 18, 2008·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Sreekumari PushpothSoupramanien Sandramouli
Apr 11, 2012·Current Opinion in Neurology·Elke V Voss, Martin Stangel
Mar 22, 2014·The New England Journal of Medicine·Kai SaukkonenLawrence R Zukerberg
Oct 30, 2015·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Domenico SambataroNicoletta Del Papa
Feb 6, 2019·Psychiatry and Clinical Neurosciences·Bogna Grygiel-GórniakMariusz Puszczewicz
May 16, 2020·International Journal of Rheumatology·Kevin John JohnThambu David Sudarsanam
Feb 5, 2010·Ocular Immunology and Inflammation·Yong-Kyu KimKyu Hyung Park
May 16, 2013·Journal of Cellular and Molecular Medicine·Rei Ogawa, Chao-Kai Hsu
Jan 29, 2016·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Tsuyoshi KasamaNao Oguro
Jan 29, 2016·HLA : Immune Response Genetics·A Paradowska-GoryckaM Jurkowska
Jul 24, 2014·The New England Journal of Medicine·Kai Saukkonen
Apr 17, 2008·Lupus·J L Callejas-RubioN Ortego-Centeno
Jun 27, 2019·Expert Opinion on Drug Safety·V S VanniP Rovere-Querini
Jan 16, 2020·Journal of Clinical Medicine·Barbara StypinskaAgnieszka Paradowska-Gorycka
Nov 3, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Mario Fabri, Nicolas Hunzelmann
May 3, 2013·The Journal of Rheumatology·Agota HajasEdit Bodolay
Jul 21, 2016·Rheumatology·Natalia C O CiangDavid A Isenberg
Mar 12, 2017·Expert Review of Respiratory Medicine·Tuang Yeow PohSanjay Haresh Chotirmall
Mar 29, 2012·Autoimmune Diseases·Adriana Rojas-VillarragaJuan-Manuel Anaya
Dec 19, 2020·The Journal of Allergy and Clinical Immunology·Yasmine LamriNicolas Charles
Jul 24, 2014·The New England Journal of Medicine·Enrico TombettiMoreno Tresoldi
May 29, 2020·Journal of Proteome Research·Álvaro Fernández-OchoaAntonio Segura-Carretero
Apr 2, 2021·Der Radiologe·Matthias Bollow
Dec 11, 2007·Best Practice & Research. Clinical Rheumatology·Martin Aringer, Josef S Smolen
Nov 7, 2009·Seminars in Diagnostic Pathology·Eric AhnJagdish Butany

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.